Phenotypic heterogeneity in British patients with a founder mutation in the FHL1 gene.
Mutations in the four-and-a-half LIM domain 1 (FHL1) gene, which encodes a 280-amino-acid protein containing four LIM domains and a single zinc-finger domain in the N-terminal region, have been associated with a broad clinical spectrum of X-linked muscle diseases encompassing a variety of different...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2011
|
| _version_ | 1826261325936852992 |
|---|---|
| author | Sarkozy, A Windpassinger, C Hudson, J Dougan, C Lecky, B Hilton-Jones, D Eagle, M Charlton, R Barresi, R Lochmüller, H Bushby, K Straub, V |
| author_facet | Sarkozy, A Windpassinger, C Hudson, J Dougan, C Lecky, B Hilton-Jones, D Eagle, M Charlton, R Barresi, R Lochmüller, H Bushby, K Straub, V |
| author_sort | Sarkozy, A |
| collection | OXFORD |
| description | Mutations in the four-and-a-half LIM domain 1 (FHL1) gene, which encodes a 280-amino-acid protein containing four LIM domains and a single zinc-finger domain in the N-terminal region, have been associated with a broad clinical spectrum of X-linked muscle diseases encompassing a variety of different phenotypes. Patients might present with a scapuloperoneal myopathy, a myopathy with postural muscle atrophy and generalized hypertrophy, an Emery-Dreifuss muscular dystrophy, or an early onset myopathy with reducing bodies. It has been proposed that the phenotypic variability is related to the position of the mutation within the FHL1 gene. Here, we report on three British families with a heterogeneous clinical presentation segregating a single FHL1 gene mutation and haplotype, suggesting that this represents a founder mutation. The underlying FHL1 gene mutation was detected by direct sequencing and the founder effect was verified by haplotype analysis of the FHL1 gene locus. A 3-bp insertion mutation (p.Phe127_Thr128insIle) within the second LIM domain of the FHL1 gene was identified in all available affected family members of the three families. Haplotype analysis of the FHL1 region on Xq26 revealed that the families shared a common haplotype. The p.Phe127_Thr128insIle mutation in the FHL1 gene therefore appears to be a British founder mutation and FHL1 gene screening, in particular of exon 6, should therefore be indicated in British patients with a broad phenotypic spectrum of X-linked muscle diseases. |
| first_indexed | 2024-03-06T19:19:37Z |
| format | Journal article |
| id | oxford-uuid:19a0221e-ad26-42ab-b795-9809b1504915 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T19:19:37Z |
| publishDate | 2011 |
| record_format | dspace |
| spelling | oxford-uuid:19a0221e-ad26-42ab-b795-9809b15049152022-03-26T10:49:58ZPhenotypic heterogeneity in British patients with a founder mutation in the FHL1 gene.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:19a0221e-ad26-42ab-b795-9809b1504915EnglishSymplectic Elements at Oxford2011Sarkozy, AWindpassinger, CHudson, JDougan, CLecky, BHilton-Jones, DEagle, MCharlton, RBarresi, RLochmüller, HBushby, KStraub, VMutations in the four-and-a-half LIM domain 1 (FHL1) gene, which encodes a 280-amino-acid protein containing four LIM domains and a single zinc-finger domain in the N-terminal region, have been associated with a broad clinical spectrum of X-linked muscle diseases encompassing a variety of different phenotypes. Patients might present with a scapuloperoneal myopathy, a myopathy with postural muscle atrophy and generalized hypertrophy, an Emery-Dreifuss muscular dystrophy, or an early onset myopathy with reducing bodies. It has been proposed that the phenotypic variability is related to the position of the mutation within the FHL1 gene. Here, we report on three British families with a heterogeneous clinical presentation segregating a single FHL1 gene mutation and haplotype, suggesting that this represents a founder mutation. The underlying FHL1 gene mutation was detected by direct sequencing and the founder effect was verified by haplotype analysis of the FHL1 gene locus. A 3-bp insertion mutation (p.Phe127_Thr128insIle) within the second LIM domain of the FHL1 gene was identified in all available affected family members of the three families. Haplotype analysis of the FHL1 region on Xq26 revealed that the families shared a common haplotype. The p.Phe127_Thr128insIle mutation in the FHL1 gene therefore appears to be a British founder mutation and FHL1 gene screening, in particular of exon 6, should therefore be indicated in British patients with a broad phenotypic spectrum of X-linked muscle diseases. |
| spellingShingle | Sarkozy, A Windpassinger, C Hudson, J Dougan, C Lecky, B Hilton-Jones, D Eagle, M Charlton, R Barresi, R Lochmüller, H Bushby, K Straub, V Phenotypic heterogeneity in British patients with a founder mutation in the FHL1 gene. |
| title | Phenotypic heterogeneity in British patients with a founder mutation in the FHL1 gene. |
| title_full | Phenotypic heterogeneity in British patients with a founder mutation in the FHL1 gene. |
| title_fullStr | Phenotypic heterogeneity in British patients with a founder mutation in the FHL1 gene. |
| title_full_unstemmed | Phenotypic heterogeneity in British patients with a founder mutation in the FHL1 gene. |
| title_short | Phenotypic heterogeneity in British patients with a founder mutation in the FHL1 gene. |
| title_sort | phenotypic heterogeneity in british patients with a founder mutation in the fhl1 gene |
| work_keys_str_mv | AT sarkozya phenotypicheterogeneityinbritishpatientswithafoundermutationinthefhl1gene AT windpassingerc phenotypicheterogeneityinbritishpatientswithafoundermutationinthefhl1gene AT hudsonj phenotypicheterogeneityinbritishpatientswithafoundermutationinthefhl1gene AT douganc phenotypicheterogeneityinbritishpatientswithafoundermutationinthefhl1gene AT leckyb phenotypicheterogeneityinbritishpatientswithafoundermutationinthefhl1gene AT hiltonjonesd phenotypicheterogeneityinbritishpatientswithafoundermutationinthefhl1gene AT eaglem phenotypicheterogeneityinbritishpatientswithafoundermutationinthefhl1gene AT charltonr phenotypicheterogeneityinbritishpatientswithafoundermutationinthefhl1gene AT barresir phenotypicheterogeneityinbritishpatientswithafoundermutationinthefhl1gene AT lochmullerh phenotypicheterogeneityinbritishpatientswithafoundermutationinthefhl1gene AT bushbyk phenotypicheterogeneityinbritishpatientswithafoundermutationinthefhl1gene AT straubv phenotypicheterogeneityinbritishpatientswithafoundermutationinthefhl1gene |